(Q43593969)

25 November 2017

Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption (English)

1 reference

25 November 2017

0 references

M F Stromberg

1

1 reference

25 November 2017

S A Mackler

series ordinal

2

1 reference

25 November 2017

J R Volpicelli

series ordinal

3

1 reference

25 November 2017

C P O'Brien

series ordinal

4

1 reference

25 November 2017

1 February 2001

1 reference

25 November 2017

1 reference

25 November 2017

23

1 reference

25 November 2017

109-116

1 reference

25 November 2017

2

1 reference

Mechanism of action of acamprosate. Part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex.

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Acamprosate enhances N-methyl-D-apartate receptor-mediated neurotransmission but inhibits presynaptic GABA(B) receptors in nucleus accumbens neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Acamprosate, but not naltrexone, inhibits conditioned abstinence behaviour associated with repeated ethanol administration and exposure to a plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Ethanol withdrawal seizures and the NMDA receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Chronic ethanol ingestion decreases vasopressin mRNA in hypothalamic and extrahypothalamic nuclei of mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Increased ethanol self-administration after a period of imposed ethanol deprivation in rats trained in a limited access paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Ethanol and the NMDA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

N-methyl-D-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Injections of N-methyl-D-aspartate into the ventral hippocampus increase extracellular dopamine in the ventral tegmental area and nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Dose-dependent suppression of the high alcohol intake of chronically intoxicated rats by Ca-acetyl homotaurinate

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Increasing the rate of ethanol consumption in food- and water-satiated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Cyamemazine decreases ethanol intake in rats and convulsions during ethanol withdrawal syndrome in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Decreased brain reward produced by ethanol withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Effect of ethanol on extracellular 5-HT and glutamate in the nucleus accumbens and prefrontal cortex: comparison between the Lewis and Fischer 344 rat strains

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Acamprosate and alcohol: II. Effects on alcohol withdrawal in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Effects of naltrexone administered repeatedly across 30 or 60 days on ethanol consumption using a limited access procedure in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

The NMDA receptor partial agonist, 1-aminocyclopropanecarboxylic acid (ACPC), reduces ethanol consumption in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Naltrexone in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Naltrexone and alcohol dependence. Role of subject compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Effect of naltrexone on alcohol "high" in alcoholics.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

Biochemical evidence for overlapping neocortical and allocortical glutamate projections to the nucleus accumbens and rostral caudatoputamen in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2800%2900137-3

7 January 2021

10.1016/S0741-8329(00)00137-3

Identifiers

DOI

1 reference

25 November 2017

1 reference